Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations

B. Rouse, L. Lockhart, R. Matalon, C. Azen, R. Koch, W. Hanley, H. Levy, F. dela Cruz, E. Friedman

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

It is clear from the preliminary data that major malformations, i.e. intrauterine growth retardation, microcephaly and cardiac defects, tend to decrease in frequency as the blood phenylalanine level drops, but not enough to suggest that phenylalanine levels of 600 μmol/L are safe levels. The facial dysmorphic features may be used as a sensitive indicator that blood phenylalanine levels should be below 360 μmol/L. It is hoped that at the end of the collaborative study more data will be available to suggest blood phenylalanine levels which will prevent the deleterious effects of maternal PKU syndrome.

Original languageEnglish (US)
Pages (from-to)289-291
Number of pages3
JournalJournal of Inherited Metabolic Disease
Volume13
Issue number3
DOIs
StatePublished - May 1 1990
Externally publishedYes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations'. Together they form a unique fingerprint.

  • Cite this